The New York State Teachers Retirement System decreased its holdings of Regeneron Pharmaceuticals by 1.1% in the third quarter, reducing its share count by 992 shares to total 86,587 shares....

Cantor Fitzgerald Investment Advisors L.P. increased its holdings of Bristol Myers Squibb Company shares by 6.7% in the third quarter, purchasing an additional 18,267 shares to reach a total of 289,71...

Regatta Capital Group LLC has recently acquired 4,062 shares of Gilead Sciences Inc., valued at approximately $451,000, according to their latest filing with the SEC. This investment was made during t...

Toth Financial Advisory Corp decreased its stake in Catalyst Pharmaceuticals Inc by 96.5% during the third quarter, reducing its holdings from prior levels to a current ownership of 2,150 shares value...

Assenagon Asset Management S.A. reported an increase of 76.1% in its holdings of Insmed Inc., adding 55,841 shares to reach a total holding of 129,245 shares during the third quarter....

GRIMES & Co Wealth Management LLC has decreased its holdings of Bristol Myers Squibb Company (BMY) by selling 22,215 shares in the third quarter, bringing their total to 375,643 shares....

Hennion & Walsh Asset Management Inc. decreased its stake in Regeneron Pharmaceuticals by 53.5% during the third quarter, selling 1,206 shares and retaining ownership of 1,047 shares....

Cardinal Capital Management recently purchased 17,768 shares in Halozyme Therapeutics Inc., representing a valuation of about $1.3 million as reported to the SEC on its most recent Form 13F filing....

Clear Harbor Asset Management LLC has increased its stake in Regeneron Pharmaceuticals Inc. by 26.3% during the third quarter of the year as per filings with the SEC. The institutional investor's owne...

During the 3rd quarter, Perigon Wealth Management LLC purchased a new stake in Incyte Corporation by acquiring 5,365 shares worth approximately $455,000. The firm is one of several institutional inves...